Share of U.S. children born 2017-2020 with select vaccinations by age 24 months

Percentage of children in the United States born during 2017-2020 who had received select vaccinations by age 24 months

Characteristic2017-20182019-2020
DTaP (≥3 doses) 93.6% 93.8%
DTaP (≥4 doses) 81.6% 81%
Poliovirus (≥3 doses) 92.6% 93%
MMR (≥1 dose) 91.3% 91.6%
Hib (primary series) 92.8% 93.4%
Hib (full series) 79.6% 79.1%
HepB (birth dose) 78.1% 81.5%
HepB (≥3 doses) 91.8% 92.1%
VAR (≥1 dose) 90.5% 91.1%
PCV (≥3 doses) 92.4% 92.8%
PCV (≥4 doses) 82.2% 82.7%
HepA (≥1 dose) 86.9% 88.4%
HepB (≥2 doses by age 35 mos) 46.4% 47.7%
Created with Highcharts 7.2.2Percentage of children93.8%93.8%81%81%93%93%91.6%91.6%93.4%93.4%79.1%79.1%81.5%81.5%92.1%92.1%91.1%91.1%92.8%92.8%82.7%82.7%88.4%88.4%47.7%47.7%76.6%76.6%61.3%61.3%69.1%69.1%1%1%93.6%93.6%81.6%81.6%92.6%92.6%91.3%91.3%92.8%92.8%79.6%79.6%78.1%78.1%91.8%91.8%90.5%90.5%92.4%92.4%82.2%82.2%86.9%86.9%46.4%46.4%75.7%75.7%60.6%60.6%70%70%1%1%2017-20182019-2020DTaP (≥3 doses)DTaP (≥4 doses)Poliovirus (≥3 doses)MMR (≥1 dose)Hib (primary series)Hib (full series)HepB (birth dose)HepB (≥3 doses)VAR (≥1 dose)PCV (≥3 doses)PCV (≥4 doses)HepA (≥1 dose)HepB (≥2 doses by age 35 mos)Rotavirus (by age 8 mos)Influenza (≥2 doses)***Combined 7-vaccine seriesNo vaccinations
0%5%10%15%20%25%30%35%40%45%50%55%60%65%70%75%80%85%90%95%100%105%
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

November 2023

Region

United States

Survey time period

2017-2018 and 2019-2020

Age group

0-24 months

Supplementary notes

DTaP = diphtheria, tetanus toxoids, and acellular pertussis vaccine; HepA = hepatitis A vaccine; HepB = hepatitis B vaccine; Hib = Haemophilus influenzae type b conjugate vaccine; MMR = measles, mumps, and rubella vaccine; PCV = pneumococcal conjugate vaccine; VAR = varicella vaccine.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Leading companies trust Statista:
paypal google adobe pg samsung telekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on " Hepatitis in the U.S. "

Other statistics that may interest you Hepatitis in the U.S.

Overview

6

Hepatitis A

5

Hepatitis B

7

Hepatitis C

8

Further related statistics

6

Discover Statista

Need help with using Statista for your research? Tutorials and first steps
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Learn more about how Statista can support your business.